Status:
RECRUITING
Evaluation of the Efficacy of "Lifespan Integration" (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder
Lead Sponsor:
Centre Hospitalier St Anne
Conditions:
Post-Traumatic Stress Disorder Complex
Psychiatric Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD
Eligibility Criteria
Inclusion
- patients diagnosed with complex PTSD
- French speaking
- first time following an LI type of therapy
- psychotropic treatment is allowed
Exclusion
- no other parallel psychotherapy is accepted (if the patient underwent recently any other type of psychotherapy, a "wash out " period of minimum 4 weeks is required )
- no active manic episode at the time of inclusion
- no active psychotic episode at the time of inclusion
- no chronic psychotic disorder diagnosis
- no autistic spectrum disorder diagnosis ,
- no intellectual deficit
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06535243
Start Date
April 1 2024
End Date
April 1 2027
Last Update
August 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU St Anne
Paris, Île-de-France Region, France, 75014